187 related articles for article (PubMed ID: 23244701)
1. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20' urea derivatives.
Leggans EK; Duncan KK; Barker TJ; Schleicher KD; Boger DL
J Med Chem; 2013 Feb; 56(3):628-39. PubMed ID: 23244701
[TBL] [Abstract][Full Text] [Related]
2. New prospects for vinblastine analogues as anticancer agents.
Silvestri R
J Med Chem; 2013 Feb; 56(3):625-7. PubMed ID: 23316748
[TBL] [Abstract][Full Text] [Related]
3. Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20' ethyl substituent.
Allemann O; Cross RM; Brütsch MM; Radakovic A; Boger DL
Bioorg Med Chem Lett; 2017 Jul; 27(14):3055-3059. PubMed ID: 28551101
[TBL] [Abstract][Full Text] [Related]
4. Ultra-potent vinblastine analogues improve on-target activity of the parent microtubulin-targeting compound.
Radakovic A; Boger DL
Bioorg Med Chem Lett; 2019 Jun; 29(11):1370-1374. PubMed ID: 30952593
[TBL] [Abstract][Full Text] [Related]
5. Potent Vinblastine C20' Ureas Displaying Additionally Improved Activity Against a Vinblastine-Resistant Cancer Cell Line.
Barker TJ; Duncan KK; Otrubova K; Boger DL
ACS Med Chem Lett; 2013 Sep; 4(10):985-8. PubMed ID: 24223237
[TBL] [Abstract][Full Text] [Related]
6. Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.
Carney DW; Lukesh JC; Brody DM; Brütsch MM; Boger DL
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9691-8. PubMed ID: 27512044
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.
Ishikawa H; Colby DA; Seto S; Va P; Tam A; Kakei H; Rayl TJ; Hwang I; Boger DL
J Am Chem Soc; 2009 Apr; 131(13):4904-16. PubMed ID: 19292450
[TBL] [Abstract][Full Text] [Related]
8. High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs.
Radakovic A; Boger DL
Bioorg Med Chem Lett; 2018 Mar; 28(5):863-865. PubMed ID: 29439899
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
10. Iron(III)/NaBH4-mediated additions to unactivated alkenes: synthesis of novel 20'-vinblastine analogues.
Leggans EK; Barker TJ; Duncan KK; Boger DL
Org Lett; 2012 Mar; 14(6):1428-31. PubMed ID: 22369097
[TBL] [Abstract][Full Text] [Related]
11. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
Potier P
Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
Jordan MA; Himes RH; Wilson L
Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
[TBL] [Abstract][Full Text] [Related]
13. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues.
Tam A; Gotoh H; Robertson WM; Boger DL
Bioorg Med Chem Lett; 2010 Nov; 20(22):6408-10. PubMed ID: 20932748
[TBL] [Abstract][Full Text] [Related]
14. Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.
Lukesh JC; Carney DW; Dong H; Cross RM; Shukla V; Duncan KK; Yang S; Brody DM; Brütsch MM; Radakovic A; Boger DL
J Med Chem; 2017 Sep; 60(17):7591-7604. PubMed ID: 28857558
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of 5a'-homo-vinblastine and congeners designed to establish structural determinants for isolation of atropisomers.
Kuehne ME; Cowen SD; Xu F; Borman LS
J Org Chem; 2001 Aug; 66(16):5303-16. PubMed ID: 11485449
[TBL] [Abstract][Full Text] [Related]
16. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine].
Tsvetkov FO; Kulikova AA; Devred F; Zerniĭ EIu; Lafitte D; Makarov AA
Mol Biol (Mosk); 2011; 45(4):697-702. PubMed ID: 21954603
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives.
Va P; Campbell EL; Robertson WM; Boger DL
J Am Chem Soc; 2010 Jun; 132(24):8489-95. PubMed ID: 20518465
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign.
Schleicher KD; Sasaki Y; Tam A; Kato D; Duncan KK; Boger DL
J Med Chem; 2013 Jan; 56(2):483-95. PubMed ID: 23252481
[TBL] [Abstract][Full Text] [Related]
19. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties.
Sears JE; Boger DL
Acc Chem Res; 2015 Mar; 48(3):653-62. PubMed ID: 25586069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
